Table 3. Differences of hematologic variables according to clinicopathologic characteristics.

Characteristics		WBC		Neutrophil				Lymphocyte				NLR
		Absolute count		Absolute count		Percentage		Absolute count		Percentage
		Mean±SD	P-value	Mean±SD	P-value	Mean±SD	P-value	Mean±SD	P-value	Mean±SD	P-value	Mean±SD	P-value
Age group			0.027		0.013		0.011		<0.001		0.002		0.002
	≤50	8,601±2,998		5,931±2,823		66.7±11.6		1,887±686		23.9±10.0		3.71±3.04
	51–60	7,598±2,621		5,122±2,260		65.6±9.9		1,768±570		24.9±8.7		3.11±1.53
	>60	7,983±2,668		5,135±2,259		62.9±11.0		2,109±760		27.7±9.5		2.78±1.73
FIGO stage			0.005		<0.001		0.002		0.146		<0.001		0.016
	IIB	7,698±2,429		5,011±2,123		63.6±11.0		1,976±737		27.0±9.6		2.97±2.29
	IIIA, IIIB, IVA	8,787±3,285		6,111±2,922		67.4±10.4		1,866±606		23.1±8.8		3.53±1.88
Tumor size (mm)			<0.001		<0.001		<0.001		0.074		<0.001		<0.001
	≤50	7,437±2,341		4,783±2,065		62.8±10.9		1,993±721		28.0±9.4		2.77±2.15
	>50	8,875±3,103		6,158±2,729		67.6±10.5		1,865±664		22.7±8.9		3.67±2.12
Histology			0.237		0.213		0.321		0.281		0.089		0.13
	SCC	8,089±2,790		5,406±2,475		65.0±11.0		1,930±690		25.5±9.5		3.20±2.23
	Others	7,469±2,549		4,783±2,186		62.8±10.3		2,084±815		28.8±9.4		2.53±1.23
LN metastasis			0.143		0.018		0.004		0.012		<0.001		0.047
	No	7,751±2,496		5,008±2,209		62.9±11.4		2,051±747		28.0±9.9		2.88±2.45
	Yes	8,248±2,939		5,605±2,592		66.2±10.4		1,866±656		24.3±9.0		3.33±1.96
Treatment result			0.002		<0.001		0.001		0.026		<0.001		0.001
	CR	7,889±2,698		5,205±2,379		64.2±11.0		1,961±714		26.4±9.5		3.03±2.16
	PD	9,487±3,085		6,810±2,730		70.4±9.4		1,753±515		20.0±7.8		4.21±2.09

WBC, white blood cell; NLR, neutrophil-to-lymphocyte ratio; FIGO, International Federation of Gynecology and Obstetrics; SCC, squamous cell carcinoma; LN, lymph node; CR, complete remission; PD, persistent disease.